Dapsone and doxycycline could be potential treatment modalities for COVID-19.

Farouk, Ahmed; Salman, Samar

Farouk, Ahmed; Salman, Samar.

Farouk A; Department of Dermatology and Venereology, Kafr Elsheikh General Hospital, Kafr El Sheikh City 31155, Egypt.
Salman S; Department of Dermatology and Venereology, Tanta University Hospital, Faculty of Medicine, Tanta University, Tanta, Egypt.

Med Hypotheses ; 140: 109768, 2020 07.

Article in English | MEDLINE | ID: covidwho-102173

Subject(s)

Anti-Inflammatory Agents/therapeutic use; Betacoronavirus; Coronavirus Infections/drug therapy; Cytokine Release Syndrome/drug therapy; Dapsone/therapeutic use; Doxycycline/therapeutic use; Pandemics; Pneumonia, Viral/drug therapy; Pulmonary Fibrosis/drug therapy; Anti-Inflammatory Agents/pharmacology; COVID-19; Chemotaxis, Leukocyte/drug effects; Coronavirus Infections/complications; Cytokine Release Syndrome/etiology; Cytokine Release Syndrome/prevention & control; Dapsone/pharmacology; Doxycycline/pharmacology; Humans; Neutrophils/drug effects; Pneumonia, Viral/complications; Pulmonary Fibrosis/etiology; Pulmonary Fibrosis/prevention & control; SARS-CoV-2; Th1 Cells/drug effects; Th1 Cells/immunology; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Pulmonary Fibrosis / Doxycycline / Coronavirus Infections / Dapsone / Pandemics / Betacoronavirus / Cytokine Release Syndrome / Anti-Inflammatory Agents Topics: Long Covid Limits: Humans Language: English Journal: Med Hypotheses Year: 2020 Document Type: Article Affiliation country: J.mehy.2020.109768

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google